The galectin-3 Inhibitors project tests a small molecule under development for peripheral indications for treating neuroinflammation in an Alzheimer’s mouse model.
Relieva is redefining therapeutic innovation through the world’s first proprietary cannabis and hemp pre-roll blend engineered for targeted pain relief.
eDMT Commons enables shared governance over multiple R&D efforts into how the brain regulates its own DMT.
HairDAO is an open-source R&D network where patients and researchers collaborate to develop revolutionary new treatments for hair loss.
The first human trial that will tell you - with blood - which training actually grows your brain.
Neuron-Gale
Relieva
eDMT Commons
HairDAO
Holi
0.43%
